摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

Copper;2-amino-3-(4-hydroxyphenyl)propanoate | 12320-32-0

中文名称
——
中文别名
——
英文名称
Copper;2-amino-3-(4-hydroxyphenyl)propanoate
英文别名
——
Copper;2-amino-3-(4-hydroxyphenyl)propanoate化学式
CAS
12320-32-0;14407-55-7;15392-80-0;15417-71-7;18750-45-3;25319-18-0;67336-56-5
化学式
C18H20CuN2O6
mdl
——
分子量
423.913
InChiKey
VEGMEJOSPCRZGL-UHFFFAOYSA-L
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    -1.98
  • 重原子数:
    27
  • 可旋转键数:
    4
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.22
  • 拓扑面积:
    173
  • 氢给体数:
    4
  • 氢受体数:
    8

反应信息

  • 作为反应物:
    描述:
    四苯基卟啉Copper;2-amino-3-(4-hydroxyphenyl)propanoate二甲基亚砜 为溶剂, 生成 (tetraphenylporphyrin)copper(II)
    参考文献:
    名称:
    摘要:
    The reactions of tetraphenylporphine (H2TPP) with copper(II) chelates in DMSO were studied. alpha-Amino acids (glycine, alpha-alanine, valine, leucine, tyrosine, and glutamine) were used as chelating ligands. The study of the reaction kinetics showed that Cu(II) chelates with alanine and the other amino acids are less reactive in these reactions than acetylacetonates, alpha-nitroso-beta-naphtholates, and hydroxyquinolates. The exception is a Cu(II) complex with tyrosine. The relationship between the structure of the above chelates and the rate of their reactions with porphyrin was determined.
    DOI:
    10.1023/a:1021102814028
点击查看最新优质反应信息

文献信息

  • Process to obtain new mixed copper aminoacidate complexes from phenanthrolines and their alkyl derivatives to be used as anticancerigenic agents
    申请人:UNIVERSIDAD NACIONAL AUTONOMA DE MEXICO
    公开号:EP0434445A2
    公开(公告)日:1991-06-26
    This invention refers to a process to obtain new mixed copper aminoacidates from phenanthrolines and their alkyl derivates of an aromatic type to be used as anticancerigenic, agents preferably with a therapeutic use for the treatment of liquid and solid cancerigenic tumours such as leukemia. The complexes obtained are of the [Cu (N-N) (N-O)]⁺⁻ NO₃ type in which the N-N ligand corresponds to 4, 7-dimethyl-1, 10 phenanthroline and the N-O ligand preferably correponds to one of the aminoacidates such as tyrosine-alaninate, treoninate, triptophanate, valinate, isoleucinate, cisteinate, diglycinate, phenylalaninate, glycinate, hystidinate, serinate, tyrosinate, aspartate, alaninate and phenylalaninate. The process is characterized because it includes the following steps: making an aqueous solution based on an aliphatic alcohol and 4, 7-dimethyl-1, 10 phenanthroline react with a copper complex preferably CuNO₃5H₂O at room temperature, and immediately after making the obtained product react in an aqueous aminoacidate solution adjusting a slightly alkaline pH.
    本发明涉及一种从罗啉及其芳香族烷基衍生物中获得新的混合氨基酸的工艺,该工艺可用作抗癌剂,优选用于治疗液态和固态致癌肿瘤,如白血病。所获得的配合物为[Cu (N-N) (N-O)]⁺- NO₃型,其中 N-N 配体对应于 4,7-二甲基-1,10-罗啉,N-O 配体最好对应于氨基酸盐之一,如酪氨酸酸盐、曲安酸盐、三色酸盐、酸、三色酸、缬酸、异亮氨酸肌氨酸、二甘酸、苯丙酸、甘酸、胱酸、丝氨酸酪氨酸、天门冬酸、丙酸和苯丙酸。该工艺的特点是包括以下步骤:在室温下,使基于脂肪醇和 4,7-二甲基-1,10-罗啉的溶液与络合物(最好是 CuNO₃5H₂O)反应,然后立即使得到的产物在调节 pH 值为微碱性的氨基酸溶液中反应。
  • Composition for promoting healthy bone structure
    申请人:——
    公开号:US20030059481A1
    公开(公告)日:2003-03-27
    A dietary supplement for benefitting human bone health includes a calcium source, a source of vitamin D activity, and an osteoblast stimulant. A preferred calcium source is microcrystalline hydroxyapatite, which also contains protein (mostly collagen), phosphorus, fat, and other minerals. A preferred source of vitamin D activity is cholecalciferol, and a preferred osteoblast stimulant is ipriflavone. In addition to these basic ingredients, the composition can further include various other minerals known to occur in bone, vitamin C, and glucosamine sulfate, all of which exert beneficial effects on growth and maintenance of healthy bone. A method for benefitting human bone health involves administering a daily regimen of the dietary supplement.
    一种有益于人体骨骼健康的膳食补充剂包括一种源、一种维生素 D 活性源和一种成骨细胞刺激剂。首选的源是微晶羟磷灰石,它还含有蛋白质(主要是胶原蛋白)、、脂肪和其他矿物质。维生素 D 活性的首选来源是胆化醇,刺激成骨细胞的首选成分是异丙基三黄酮。除了这些基本成分外,组合物还可进一步包括已知存在于骨骼中的其他各种矿物质、维生素 C 和硫酸氨基葡萄糖,所有这些成分都对健康骨骼的生长和维持产生有益的影响。有益于人体骨骼健康的方法包括每天服用这种膳食补充剂。
  • DIETARY SUPPLEMENTS COMPRISING VITAMINS AND MINERALS
    申请人:LifeScience Corporation
    公开号:EP0514451B1
    公开(公告)日:1997-01-15
  • COMPOSITIONS AND METHODS FOR THE PRESERVATION OF WOOD
    申请人:Abou-Nemeh Ibrahim
    公开号:US20070227399A1
    公开(公告)日:2007-10-04
    The present invention provides compositions and methods for preserving wood. The compositions generally include at least one metal chelate or metal salt of a hydroxy analog of methionine. The method generally involves contacting wood or a wood material with a wood preservation composition of the invention. The invention also includes wood or wood products treated with a wood preservation composition of the invention.
  • Methods for determining the metal bioavailability of metal sources
    申请人:Richards James David
    公开号:US20080090297A1
    公开(公告)日:2008-04-17
    The invention provides methods for determining the relative metal bioavailability of a metal source in an animal or group of animals. The method may be utilized to compare the relative metal bioavailability between different metal sources and it may be used to determine the relative nutritional status of a metal in an animal or group of animals.
查看更多

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[[[(1R,2R)-2-[[[3,5-双(叔丁基)-2-羟基苯基]亚甲基]氨基]环己基]硫脲基]-N-苄基-N,3,3-三甲基丁酰胺 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,4R)-Boc-4-环己基-吡咯烷-2-羧酸 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-N,3,3-三甲基-N-(苯甲基)丁酰胺 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S)-2-氨基-3,3-二甲基-N-2-吡啶基丁酰胺 (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,5R,6R)-5-(1-乙基丙氧基)-7-氧杂双环[4.1.0]庚-3-烯-3-羧酸乙基酯 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素(1-6) 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸